Adrenomedullin and Adrenomedullin Binding Protein-1 Protect Endothelium-Dependent Vascular Relaxation in Sepsis
Authors:
- Subir R. MaitraSMSubir R. Maitra
- Ping WangPWPing Wang
Open Access
- 1 September 2007
- journal article
- research article
- Published by Springer Nature in Molecular Medicine
- Vol. 13 (9-10) , 488-494
Abstract
Downregulation of vascular endothelial constitutive nitric oxide synthase (ecNOS) contributes to the vascular hyporesponsiveness in sepsis. Although coadministration of the potent vasodilatory peptide adrenomedulin (AM) and the newly discovered AM binding protein (AMBP-1) maintains cardiovascular stability and reduces mortality in sepsis, it remains unknown whether AM/AMBP-1 prevents endothelial cell dysfunction. To investigate this possibility, we subjected adult male rats to sepsis by cecal ligation and puncture (CLP), with or without subsequent intravenous administration of the combination of AM (12 microg/kg) and AMBP-1 (40 microg/kg). Thoracic aortae were harvested 20 h after CLP (i.e., the late stage of sepsis) and endothelium-dependent vascular relaxation was determined by the addition of acetylcholine (ACh) in an organ bath system. In addition, ecNOS gene and protein expression was assessed by RT-PCR and immunohistochemistry, respectively. The results indicate that ACh-induced (i.e., endothelium-dependent) vascular relaxation was significantly reduced 20 h after CLP. Administration of AM/AMBP-1 prevented the reduction of vascular relaxation. In addition, ecNOS gene expression in aortic and pulmonary tissues was downregulated 20 h after CLP and AM/AMBP-1 attenuated such a reduction. Moreover, the decreased ecNOS staining in thoracic aortae of septic animals was prevented by the treatment with AM/AMBP-1. These results, taken together, indicate that AM/AMBP-1 preserves ecNOS and prevents reduced endothelium-dependent vascular relaxation (i.e., endothelial cell dysfunction) in sepsis. In light of our recent finding that AM/AMBP-1 improves organ function and reduces mortality in sepsis, it is most likely that the protective effect of these compounds on ecNOS is a mechanism responsible for the salutary effect of AM/AMBP-1 in sepsis.Keywords
This publication has 55 references indexed in Scilit:
- Adrenomedullin and Adrenomedullin Binding Protein-1 Attenuate Vascular Endothelial Cell Apoptosis in SepsisAnnals of Surgery, 2004
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Novel Approach to Prevent the Transition From the Hyperdynamic Phase to the Hypodynamic Phase of SepsisAnnals of Surgery, 2002
- Adrenomedullin suppresses interleukin‐1β‐induced tumor necrosis factor‐α production in Swiss 3T3 cellsFEBS Letters, 1999
- Endotoxin Markedly Elevates Plasma Concentration and Gene Transcription of Adrenomedullin in RatBiochemical and Biophysical Research Communications, 1995
- Adrenomedullin Inhibits the Secretion of Cytokine-Induced Neutrophil Chemoattractant, a Member of the Interleukin-8 Family, from Rat Alveolar MacrophagesBiochemical and Biophysical Research Communications, 1995
- Interleukin-1, Tumor Necrosis Factor and Lipopolysaccharide Additively Stimulate Production of Adrenomedullin in Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1995
- Molecular Cloning and Biological Activities of Rat Adrenomedullin, a Hypotensive PeptideBiochemical and Biophysical Research Communications, 1993
- Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human PheochromocytomaBiochemical and Biophysical Research Communications, 1993
- Human complement factor HEuropean Journal of Biochemistry, 1991